soul trial oral semaglutide cardiovascular outcomes nejm 2025 results Novo Nordisk reports showing reduced risk with in type 2 diabetes 🔴Cardiovascular outcomes with semaglutide by

Retrieved 30 March 2022

True progress comes from medically guided decisions made with expertise and empathy, not commercial promises or overnight fixes

Before using Wegovy , tell your healthcare provider if you have any other medical conditions, including if you: have or have had problems with your pancreas or kidneys have type 2 diabetes and a history of diabetic retinopathy are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation) are pregnant or plan to become pregnant

But by the time you reach a steady maintenance dose, your body may have already adjusted to the medication, which means symptoms may be milder or happen less often